Dextroamphetamine/Amphetamine Extended-Release Capsules
Lannett is recalling 5 mg Dextroamphetamine/Amphetamine ER capsules due to a labeling mix-up where capsules contain immediate-release pellets.
Stop using the affected medication and contact your pharmacist or healthcare provider for guidance on obtaining a replacement.
Recall at a glance
- Quantity recalled
- 1392 bottles
Why it was recalled
Lannett Company is recalling 5 mg extended-release capsules because the product contains immediate-release pellets instead of the labeled extended-release formulation. This labeling mix-up may result in unintended dosing and therapeutic effects.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate…
- Lot code
- 25285401A, 2027
- Strength
- 5 mg
- NDC / UPC
- NDC 0527-0790-37
Where it was sold
Distributed nationwide.
Timeline
- Firm initiated recall
- Publicly announced
- Listed on Recall Canary
- Summary updated
Official source
Other Labeling Error recalls
Other recent recalls from Lannett Company Inc.
Editorial summary by Recall Canary · summary updated 2026-07-03 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification